Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05641532 · ClinicalTrials.gov registry record · NA
Physical Activity in Persons Newly Diagnosed With Multiple Sclerosis
A NA study of Multiple Sclerosis, MS, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT05641532: Completed NA study of Multiple Sclerosis, MS, sponsored by University of Alabama at Birmingham.
NCT05641532 is a NA study of Multiple Sclerosis, MS that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 16 participants, below the 65-participant average among 7 other Multiple Sclerosis, MS trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05641532, a NA study of Multiple Sclerosis, MS, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This single group pre-post pilot intervention will examine the feasibility and initial effect of a 12-week behavioral intervention, based on the Behavior Change Wheel and Capability-Opportunity-Motivation-Behavior (COM-B) model and remotely delivered through electronic newsletters and online one-on-one video conferencing, for promoting physical activity and secondarily reducing fatigue and quality of life in persons newly diagnosed with MS (diagnosed with MS within the past 2 years). The investigators hypothesize the proposed 12-week intervention will be feasible based on process, resource, management, and scientific outcomes. The investigators further hypothesize that individuals who receive the 12-week intervention will demonstrate an increase in physical activity behavior, particularly daily step counts, and reduce fatigue.
Primary Outcome
Process assesses participant recruitment, retention, and adherence i. Recruitment and refusal rates ii. Retention, attrition, and adherence rates to study procedures
Conditions Studied
Interventions
- BEHAVIORAL Physical activity behavioral intervention in persons newly diagnosed with MS
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-01-17 |
| Est. Completion | 2023-08-08 |
| Phase | NA |
What the finished NCT05641532 record still lists
NCT05641532 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 65-participant average among 7 other Multiple Sclerosis, MS trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Multiple Sclerosis, MS appearing as the primary indexed condition, and to 1 intervention - of which Physical activity behavioral intervention in persons newly diagnosed with MS is the first listed.
NCT05641532 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05641532 about?
NCT05641532 is a clinical study titled "Physical Activity in Persons Newly Diagnosed With Multiple Sclerosis". This single group pre-post pilot intervention will examine the feasibility and initial effect of a 12-week behavioral intervention, based on the Behavior Change Wheel and Capability-Opportunity-Motivation-Behavior (COM-B) model and remotely delivered through electronic newsletters and online one-on-...
What is the current status of trial NCT05641532?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2023-01-17. Estimated completion is 2023-08-08.
What conditions does trial NCT05641532 study?
This clinical trial studies the following conditions: Multiple Sclerosis, MS.
What interventions are being tested in trial NCT05641532?
The interventions under investigation include: Physical activity behavioral intervention in persons newly diagnosed with MS (BEHAVIORAL).
Who is sponsoring clinical trial NCT05641532?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05641532 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis, MS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Palliative Care Model Impact on Knowledge and Attitudes
RECRUITING · NA
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
RECRUITING · NA
-
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
COMPLETED · NA
-
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
RECRUITING · Phase 1
-
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
RECRUITING · Phase 1
-
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI